ArticleNeuro-oncology2012

Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastoma.

Prakash Chinnaiyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.